Health Condition 1: N719- Inflammatory disease of uterus, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Excessive Menstrual Bleeding Intermenstrual Bleeding Prolonged Bleeding Patients Willing To Participate And Provide Informed Consent In Trial
Exclusion criteria
Exclusion criteria: Uterine And Pelvic Pathology Use Of IUCD Bleeding Caused By Miscarriage Inevitable Abortion Cardiovascular Renal Coagulation Chronic Systemic Disease Bleeding Site Other Than Uterus Develop Condition Which May Require Other Treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Improve The Grading Of Menorrhagia And Duration Of BleedingTimepoint: Follow Up Will Be Done On 60 90 120 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement In The Haemoglobin Level Improvement In The Endometrial ThicknessTimepoint: Follow Up Will Be Done On 60 90 120 Days | — |
Countries
India
Contacts
Institute For Ayurved Studies And Research